JPH3 and neoplasm: By activating the JAK-STAT signaling pathway, JPH3 induced the malignant phenotype of DDP-resistant ATC cells.<h4>Conclusions</h4>JPH3 functions as a potent oncogenic driver in ATC, promoting tumor proliferation, invasion, and migration through the activation of the JAK-STAT signaling pathway.